IP Library Granted Patent US 7,473,796
Granted Patent B2
US 7,473,796 · App. 11/778,464 · Granted Jan 6, 2009

Cytotoxic agents comprising new maytansinoids

Assignee: Immunogen Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,473,796
App. No.
11/778,464
Granted
Jan 6, 2009
Kind
B2
Abstract

New thiol and disulfide-containing maytansinoids bearing a mono or di-alkyl substitution on the α-carbon atom bearing the sulfur atom are disclosed. Also disclosed are methods for the synthesis of these new maytansinoids and methods for the linkage of these new maytansinoids to cell-binding agents. The maytansinoid-cell-binding agent conjugates are useful as therapeutic agents, which are delivered specifically to target cells and are cytotoxic. These conjugates display vastly improved therapeutic efficacy in animal tumor models compared to the previously described agents.

Claims (40)

1. A compound of formula III:

wherein:

Y 2 represents (CR 7 R 8 ) l (CR 5 R 6 ) m (CR 3 R 4 ) n CR 1 R 2 SZ 2 , wherein:

R 1 and R 2 are each independently linear alkyl or alkenyl having from 1 to 10 carbon atoms, branched or cyclic alkyl or alkenyl having from 3 to 10 carbon atoms, phenyl, phenyl substituted with at least one alkyl containing from 1-4 carbon atoms, or an alkoxy, halogen or nitro, or heterocyclic aromatic or heterocyclic radical, and in addition R 2 can be H;

R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each independently H, linear alkyl or alkenyl having from 1 to 10 carbon atoms, branched or cyclic alkyl or alkenyl having from 3 to 10 carbon atoms, phenyl, phenyl substituted with at least one alkyl containing from 1-4 carbon atoms, or an alkoxy, halogen or nitro, or heterocyclic aromatic or heterocyclic radical;

l, m and n are each independently an integer of from 1 to 5, and in addition n can be 0; and

Z 2 is SR or —COR, wherein R is linear alkyl, branched alkyl or cyclic alkyl having from 1 to 10 carbon atoms, or simple aryl or aryl substituted with at least one alkyl containing from 1-4 carbon atoms, or heterocyclic aromatic or heterocyclic radical,

wherein said heterocyclic aromatic radical or said heterocyclic radical is a 3-10 membered ring containing one or two heteroatoms selected from N, O or S.

2. N-methyl-N-(4-methyl-4-methyldithio-1-oxopentyl)-alanine, N-methyl-N-[4-(R)-methyldithio-1-oxopentyl]-alanine, N-methyl-N-[4-(S)-methyldithio-1-oxopentyl]-alanine or racemic N-methyl-N-(4-methyldithio-1-oxopentyl)-alanine containing N-methyl-L-alanine, N-methyl-D-alanine, or racemic N-methylalanine.

3. A method of making N-methyl-N-(4-methyl-4-methyldithio-1-oxopentyl)-alanine containing N-methyl-L-alanine, N-methyl-D-alanine, or racemic N-methylalanine comprising:

(1) reacting isobutylene sulfide (5) with the anion of acetonitrile to give 4-mercapto-4-methyl-pentanenitrile (6);

(2) hydrolyzing (6) to give 4-mercapto-4-methylpentanoic acid (7);

(3) converting (7) into 4-methyl-4-(methyldithio)pentanoic acid (8) by reaction with methylmethanethiolsulfonate;

(4) converting (8) into N-hydroxysuccinimidyl 4-methyl-4-(methyldithio)pentanoate (9); and

(5) reacting (9) with N-methyl-L-alanine, N-methyl-D-alanine, or racemic N-methylalanine to give said N-methyl-N-(4-methyl-4-methyldithio-1-oxopentyl)-alanine containing N-methyl-L-alanine, N-methyl-D-alanine, or racemic N-methylalanine.

4. A mixture of N-methyl-N-[4-(S)-methyldithio-1-oxopentyl]-S-alanine and N-methyl-N-[4-(R)-methyldithio-1-oxopentyl]-S-alanine.

5. A method of making a mixture of N-methyl-N-[4-(S)-methyldithio-1-oxopentyl]-S-alanine and N-methyl-N-[4-(R)-methyldithio-1-oxopentyl]-S-alanine, comprising:

(1) reacting 4-mercaptopentanoic acid (12) with methylmethanethiolsulfonate to give 4-methyldithio-pentanoic acid (13);

(2) converting (13) into N-hydroxysuccinimidyl 4-methyldithio-pentanoate (14); and

(3) reacting (14) with N-methyl-L-alanine to give said mixture of N-methyl-N-[4-(S)-methyldithio-1-oxopentyl]-S-alanine and N-methyl-N-[4-(R)-methyldithio-1-oxopentyl]-S-alanine.

6. A mixture of N-methyl-N-[4-(S)-methyldithio-1-oxopentyl]-R-alanine and N-methyl-N-[4-(R)-methyldithio-1-oxopentyl]-R-alanine.

7. A method of making a mixture of N-methyl-N-[4-(R)-methyldithio-1-oxopentyl]-R-alanine and N-methyl-N-[4-(S)-methyldithio-1-oxopentyl]-R-alanine comprising:

(1) reacting 4-mercaptopentanoic acid (12) with methyl methanethiolsulfonate to give 4-methyldithio-pentanoic acid (13);

(2) converting (13) into N-hydroxysuccinimidyl 4-methyldithio-pentanoate (14);

(3) reacting (14) with N-methyl-D-alanine to give said mixture of N-methyl-N-[4-(R)-methyldithio-1-oxopentyl]-R-alanine and N-methyl-N-[4-(S)-methyldithio-1-oxopentyl]-R-alanine.

8. Racemic N-methylalanine acylated with a carboxylic group bearing a protected thiol functionality, in which the carbon center bearing the sulfur atom is either racemic or of the R or S chirality to give N-methyl-N-(4-methyldithio-1-oxopentyl)-L-alanine.

9. A method of making racemic N-methylalanine acylated with a carboxylic group bearing a protected thiol functionality, in which the carbon center bearing the sulfur atom is either racemic or of the R or S chirality to give N-methyl-N-(4-methyldithio-1-oxopentyl)-alanine, comprising:

(1) reacting 4-mercaptopentanoic acid (12) with methyl methanethiolsulfonate to give 4-methyldithio-pentanoic acid (13);

(2) converting (13) into N-hydroxysuccinimidyl 4-methyldithio-pentanoate (14);

(3) reacting (14) with racemic N-methylalanine to give said racemic N-methylalanine acylated with a carboxylic group bearing a protected thiol functionality, in which the carbon center bearing the sulfur atom is either racemic or of the R or S chirality to give N-methyl-N-(4-methyldithio-1-oxopentyl)-alanine containing N-methyl-L-alanine and N-methyl-D-alanine.

10. N-methyl-N-[4-(S)-methyldithio-1-oxopentyl]-S-alanine.

11. A method of making N-methyl-N-[4-(S)-methyldithio-1-oxopentyl]-S-alanine (15a) comprising:

(1) converting (R)-1,3-butanediol into (S)-4-(methydithio)pentanoic acid (19);

(2) converting (19) into its N-hydroxysuccinimidyl (S)-4-(methydithio)pentanoate (20); and

(3) reacting compound (20) with N-methyl-L-alanine to give said N-methyl-N-[4-(S)-methyldithio-1-oxopentyl]-S-alanine.

12. N-methyl-N-[4-(R)-methyldithio-1-oxopentyl]-S-alanine.

13. A method of making N-methyl-N-[4-(R)-methyldithio-1-oxopentyl]-S-alanine (15b) comprising:

(1) converting (S)-1,3-butanediol into (R)-4-(methydithio)pentanoic acid (24);

(2) converting (24) into its hydroxysuccinimidyl (R)-4-(methydithio)pentanoate (25); and

(3) reacting (25) with N-methyl-L-alanine to give said N-methyl-N-[4-(R)-methyldithio-1-oxopentyl]-S-alanine.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Feb 12, 2024
From: BIOPHARMA CREDIT PLC
To: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
Reel/Frame 066553/0109 →
PATENT SECURITY AGREEMENT Recorded Apr 6, 2023
From: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 063282/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2015
From: CHARI, RAVI V.J.; WIDDISON, WAYNE C.
To: IMMUNOGEN, INC.
Reel/Frame 035212/0719 →
ADDRESS CHANGE Recorded May 13, 2008
From: IMMUNOGEN, INC.
To: IMMUNOGEN, INC.
Reel/Frame 020930/0905 →
Continuity (4)
Division 1084913600 · May 20, 2004
Provisional Application 6049345700 · Aug 8, 2003
Provisional Application 6047173900 · May 20, 2003
Related Publication 20070270585A1 · Nov 22, 2007